Skip to main content
. 2023 Jan 27;59(2):236. doi: 10.3390/medicina59020236

Table 2.

Comorbidities among the study cohort.

mTKA (n = 68) NAVIO (n = 76) CORI (n = 71) p Value
Comorbidity, n (%) 57 (83.8%) 49 (64.5%) 51 (71.8%) 0.9733
Hypertension 16 (23.5%) 18 (23.7%) 19 (26.8%) 0.0782
Arrhythmias 5 (7.4%) 2 (2.7%) 0 0.8793
Hypothyroidism 5 (7.4%) 3 (3.9%) 6 (8.5%) 0.0812
Diabetes mellitus 13 (19.1 %) 16 (21.1%) 11 (15.5%) 0.0765
Asthma 3 (4.4%) 1 (1.3%) 0 0.5210
Depression 3 (4.4%) 0 1 (1.4%) 0.9854
Systemic lupus erythematosus 1 (1.5%) 0 2 (2.8%) 0.9982
Rheumatoid arthritis 3 (4.4%) 2 (2.7%) 5 (7%) 0.3965
Gout 7 (10.3%) 4 (5.3%) 5 (7%) 0.2135
Psoriatic arthritis 1 (1.5%) 3 (3.9%) 2 (2.8%) 0.0754